More on DRUG
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $59.11 |
|
|||
| Open | $60.18 | ||||
| 52 Wk High | $0.81 | ||||
| 52 Wk Low | $0.50 | ||||
| Day High | $62.26 | ||||
| Day Low | $60.18 | ||||
| P/E | 503.08 | ||||
| EPS | $0.12 | ||||
| Volume | 30,871 | ||||
- Bright Minds Biosciences to Present at Upcoming Conferences
- H.C. Wainwright Reiterates Buy Rating on Bright Minds Biosciences Inc. (DRUG)
- Form 6-K BRIGHT MINDS BIOSCIENCES For: Jun 30
- Form SCHEDULE 13G/A BRIGHT MINDS BIOSCIENCES Filed by: Cormorant Asset Management, LP
- Form S-8 BRIGHT MINDS BIOSCIENCES
- Form SCHEDULE 13G/A BRIGHT MINDS BIOSCIENCES Filed by: Adage Capital Management, L.P.
- Vistagen names neuroscience veteran Douglas Williamson to its board
- Vistagen Appoints Douglas J. Williamson to its Board of Directors
- Form SCHEDULE 13D/A BRIGHT MINDS BIOSCIENCES Filed by: McDonald Ian
- Form 6-K BRIGHT MINDS BIOSCIENCES For: Mar 31
Entities mentioned with DRUG
- 13G | View Related Stories »
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Jefferies & Co | View Related Stories »
- Cowen & Co | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Show More...
